These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26195413)

  • 1. Re: Lower Urinary Tract Symptoms Improve with Testosterone Replacement Therapy in Men with Late-Onset Hypogonadism: 5-Year Prospective, Observational and Longitudinal Registry Study.
    Griebling TL
    J Urol; 2015 Aug; 194(2):498. PubMed ID: 26195413
    [No Abstract]   [Full Text] [Related]  

  • 2. Lower urinary tract symptoms improve with testosterone replacement therapy in men with late-onset hypogonadism: 5-year prospective, observational and longitudinal registry study.
    Yassin DJ; El Douaihy Y; Yassin AA; Kashanian J; Shabsigh R; Hammerer PG
    World J Urol; 2014 Aug; 32(4):1049-54. PubMed ID: 24135918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone Replacement Therapy and BPH/LUTS. What is the Evidence?
    Baas W; Köhler TS
    Curr Urol Rep; 2016 Jun; 17(6):46. PubMed ID: 27068735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone supplementation does not worsen lower urinary tract symptoms.
    Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
    J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone and benign prostatic hyperplasia.
    Jarvis TR; Chughtai B; Kaplan SA
    Asian J Androl; 2015; 17(2):212-6. PubMed ID: 25337845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
    Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
    BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone and the Prostate: Artifacts and Truths.
    DeLay KJ; Kohler TS
    Urol Clin North Am; 2016 Aug; 43(3):405-12. PubMed ID: 27476133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of views on the etiology and pathogenesis of lower urinary tract symptoms for men].
    Tyuzikov IA; Tishova YA
    Urologiia; 2022 Nov; (5):135-141. PubMed ID: 36382832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
    Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
    Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadism.
    Meuleman EJ; Legros JJ; Bouloux PM; Johnson-Levonas AO; Kaspers MJ; Elbers JM; Geurts TB; Meehan AG;
    Aging Male; 2015; 18(3):157-63. PubMed ID: 26030346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Testosterone supplementation therapy for improvement of lower urinary tract symptoms: Progress in studies].
    Zhang ZC; Peng J
    Zhonghua Nan Ke Xue; 2020 May; 26(5):387-391. PubMed ID: 33354945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome.
    Francomano D; Ilacqua A; Bruzziches R; Lenzi A; Aversa A
    Urology; 2014 Jan; 83(1):167-73. PubMed ID: 24139347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual dysfunction in 2014: Men enjoy a year of significant progress.
    Saitz TR; Serefoglu EC
    Nat Rev Urol; 2015 Feb; 12(2):73-4. PubMed ID: 25582521
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternatives to testosterone replacement: testosterone restoration.
    McCullough A
    Asian J Androl; 2015; 17(2):201-5. PubMed ID: 25578932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlled Trials.
    Mulhall JP; Brock GB; Glina S; Baygani S; Donatucci CF; Maggi M
    J Sex Med; 2016 May; 13(5):843-51. PubMed ID: 27017071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Association of Urology Position Statement on the Role of the Urologist in the Management of Male Hypogonadism and Testosterone Therapy.
    Mirone V; Debruyne F; Dohle G; Salonia A; Sofikitis N; Verze P; Fode M; Chapple C;
    Eur Urol; 2017 Aug; 72(2):164-167. PubMed ID: 28249799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset hypogonadism a challenging task for the andrology field.
    Corona G; Krausz C
    Andrology; 2020 Nov; 8(6):1504-1505. PubMed ID: 33460316
    [No Abstract]   [Full Text] [Related]  

  • 18. Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy.
    Hassan J; Barkin J
    Can J Urol; 2016 Feb; 23(Suppl 1):20-30. PubMed ID: 26924592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone: myocardial infarction and stroke.
    Prescrire Int; 2014 Oct; 23(153):240-1. PubMed ID: 25964971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional hypogonadism in middle-aged and older men: testosterone treatment or not?
    Grossmann M; Jones TH
    Eur J Endocrinol; 2021 Aug; 185(3):D1-D9. PubMed ID: 34260411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.